-
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
Hsu MC, Huang YS, Ouyang WC (2020).
Lipids Health Dis. 19:159.
-
The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials.
Zhang MM, Zou Y, Li SM, et al. (2020).
Transl Psychiatry. 10:193.
-
Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
McNamara RK, Strawn JR, Tallman MJ, et al. (2020).
J Child Adolesc Psychopharmacol. 30:293-305.
-
High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta- analysis.
Luo XD, Feng JS, Yang Z, et al. (2020).
BMC Psychiatry. 20:248.
-
A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder.
Guu TW, Mischoulon D, Sarris J, et al. (2020).
J Affect Disord. 265:233-38.
-
Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials.
Deane KHO, Jimoh OF, Biswas P, et al. (EPub ahead of print).
Br J Psychiatry. 2019 Oct 24:1-8.
-
Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials.
Zhang L, Liu H, Kuang L, Meng H, Zhou X (2019).
Child Adolesc Psychiatry Ment Health. 13:36.
-
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW, Mischoulon D, Sarris J, et al. (2019).
Psychother Psychosom. 2019;88(5):263-73.
-
Efficacy of omega-3 PUFAs in depression: A meta-analysis.
Liao Y, Xie B, Zhang H, et al. (2019).
Transl Psychiatry. 9:190.
-
A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression.
Gabbay V, Freed RD, Alonso CM, et al. (2018).
J Clin Psychiatry. 79:17m11596.
-
A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
Mazahery H, Conlon CA, Beck KL, et al. (2019).
J Steroid Biochem Mol Biol. 187:9-16.
-
Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: A systematic review and meta-analysis.
Su KP, Tseng PT, Lin PY, et al. (2018).
JAMA Network Open. 1(5):e182327.